Aterian, INC 8-K filings

Aterian, Inc. announces the completion of its asset sale to Trademark Global and a significant equity investment from David E. Lazar, alongside the establishment of a Contingent Value Rights Agreement.

Aterian, Inc. has adjourned its special meeting of stockholders to allow for additional voting time on a proposed asset sale, with the meeting reconvening on July 17, 2026.

Aterian, Inc. has declared a contingent value rights (CVR) dividend for shareholders following its planned asset sale and investment transaction.

Aterian, Inc. has officially regained compliance with Nasdaq's minimum bid price requirement, closing a period of concern for investors.

Aterian, Inc. announced a definitive agreement to sell its marquee brand portfolio to Trademark Global, LLC for $18 million and a strategic investment of $7 million from David Lazar.

Aterian, Inc. announced its strategic alternatives process is progressing with constructive discussions aimed at maximizing shareholder value, expecting another update in mid-April.

Aterian, Inc. received a notice from Nasdaq regarding non-compliance with the minimum $1.00 bid price requirement, initiating a 180-day compliance period.

Aterian, Inc. announced its Board of Directors has initiated a formal process to evaluate strategic alternatives aimed at maximizing shareholder value.

Aterian, Inc. announced its Board of Directors will hold non-binding advisory votes on executive compensation every three years, following stockholder approval at the 2025 Annual Meeting.

Aterian, Inc. reported Q3 2025 financial results showing improved margins and narrowed Adjusted EBITDA loss sequentially, despite a year-over-year revenue decline and increased net loss.

Aterian, Inc. announced the resignation of its Chief Technology Officer, Roi Zahut, effective November 3, 2025, to pursue another executive opportunity.

Aterian, Inc. has amended its Credit and Security Agreement, modifying liquidity covenants and establishing new availability reserves with its lenders.

Aterian, Inc. announced the results of its 2025 Annual Meeting of Stockholders, where key proposals including director election and executive compensation were approved.

Aterian, Inc. reported wider losses in Q2 2025 due to tariff volatility and macroeconomic pressures, but projects improved performance in the second half of the year.

Aterian, Inc. announced that board member Sarah Liebel will retire from the Board of Directors effective at the conclusion of the 2025 Annual Meeting of Stockholders due to increased professional responsibilities.

Aterian announces its Q1 2025 financial results, highlighting a cost optimization plan to reduce annual spending by $5-$6 million amid tariff mitigation efforts.

Aterian, Inc. announces improved financial results for 2024, including narrowed losses and improved margins, and introduces a $3 million share repurchase program.

Aterian Inc. reports preliminary Q4 2024 net revenue at the higher end of guidance and outlines plans for sustainable growth in 2025, driven by omnichannel expansion and product launches.

Aterian Inc. announced a significant improvement in its third-quarter net loss, alongside achieving adjusted EBITDA profitability for the second consecutive quarter.

Aterian, Inc. has engaged William Kurtz as an advisor to senior management and held its 2024 Annual Meeting of Stockholders, where a new director was elected and the company's auditor was ratified.

Aterian, Inc. reported improved profitability in the second quarter of 2024, achieving adjusted EBITDA profitability despite a decrease in net revenue.

Cynthia Williams will not seek re-election to the Aterian Inc. Board of Directors and will retire at the conclusion of the 2024 Annual Meeting of Stockholders.

Aterian, Inc. announced the resignation of its Co-CEO, the appointment of a new CEO and CFO, and improved second-quarter revenue and adjusted EBITDA guidance.

Aterian Inc. announced a significant improvement in its first quarter net loss and adjusted EBITDA loss compared to the previous year, while affirming its target for adjusted EBITDA profitability in the second half of 2024.

Aterian has updated its Q1 2024 financial outlook, projecting improved net revenue and adjusted EBITDA ranges, and engaged with investors in a Reddit Q&A session.

Aterian, Inc. has received notification from Nasdaq that it has regained compliance with the minimum bid price requirement of $1.00 per share.

Aterian Inc. has implemented a 1-for-12 reverse stock split of its common stock, effective March 22, 2024.

Aterian's full year 2023 results show a significant decrease in net revenue but improved profitability metrics, with the company reaffirming its target for adjusted EBITDA profitability in the second half of 2024.

Aterian, Inc. has extended its credit facility with MidCap Financial, improving liquidity and extending the maturity to December 2026.

Aterian, Inc. announced a fixed cost reduction plan expected to save $4.0 million annually and improved preliminary Q4 2023 results, moving closer to profitability.